These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 20221675)
1. Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system. Lee J; Bhang SH; Park H; Kim BS; Lee KY Pharm Res; 2010 May; 27(5):767-74. PubMed ID: 20221675 [TBL] [Abstract][Full Text] [Related]
2. Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system. Lee J; Lee KY Pharm Res; 2009 Jul; 26(7):1739-44. PubMed ID: 19384466 [TBL] [Abstract][Full Text] [Related]
3. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis. Shin SH; Lee J; Lim KS; Rhim T; Lee SK; Kim YH; Lee KY J Control Release; 2013 Feb; 166(1):38-45. PubMed ID: 23262200 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis. Shin SH; Lee J; Ahn DG; Lee KY Pharm Res; 2013 Aug; 30(8):2157-65. PubMed ID: 23686375 [TBL] [Abstract][Full Text] [Related]
5. Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. Cleland JL; Duenas ET; Park A; Daugherty A; Kahn J; Kowalski J; Cuthbertson A J Control Release; 2001 May; 72(1-3):13-24. PubMed ID: 11389981 [TBL] [Abstract][Full Text] [Related]
6. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization. Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157 [TBL] [Abstract][Full Text] [Related]
7. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice. Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620 [TBL] [Abstract][Full Text] [Related]
8. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres. Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837 [TBL] [Abstract][Full Text] [Related]
9. Enzymatically cross-linked injectable alginate-g-pyrrole hydrogels for neovascularization. DeVolder R; Antoniadou E; Kong H J Control Release; 2013 Nov; 172(1):30-37. PubMed ID: 23886705 [TBL] [Abstract][Full Text] [Related]
10. Polymers for induction of revascularization in the rat fascial flap: application of vascular endothelial growth factor and pancreatic islet cells. Linn T; Erb D; Schneider D; Kidszun A; Elçin AE; Bretzel RG; Elçin YM Cell Transplant; 2003; 12(7):769-78. PubMed ID: 14653623 [TBL] [Abstract][Full Text] [Related]
11. Local sustained release of prostaglandin E1 induces neovascularization in murine hindlimb ischemia. Esaki J; Sakaguchi H; Marui A; Bir SC; Arai Y; Huang Y; Tsubota H; Kanaji T; Ikeda T; Sakata R Circ J; 2009 Jul; 73(7):1330-6. PubMed ID: 19436117 [TBL] [Abstract][Full Text] [Related]
12. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Matsui M; Tabata Y Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581 [TBL] [Abstract][Full Text] [Related]
13. How do poly lactide-co-glycolide microspheres for prostaglandin E1 operate in ischemic tissue? Local sustained release of prostaglandin E1 induces neovascularization in murine hindlimb ischemia. Okazaki T; Aoyagi S Circ J; 2009 Jul; 73(7):1201-2. PubMed ID: 19556701 [No Abstract] [Full Text] [Related]
14. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
15. Gelatin-based micro-hydrogel carrying genetically engineered human endothelial cells for neovascularization. Choi YH; Kim SH; Kim IS; Kim K; Kwon SK; Hwang NS Acta Biomater; 2019 Sep; 95():285-296. PubMed ID: 30710712 [TBL] [Abstract][Full Text] [Related]
16. Injectable PLGA microspheres encapsulating WKYMVM peptide for neovascularization. Choi YH; Heo SC; Kwon YW; Kim HD; Kim SH; Jang IH; Kim JH; Hwang NS Acta Biomater; 2015 Oct; 25():76-85. PubMed ID: 26216508 [TBL] [Abstract][Full Text] [Related]
18. Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis. Daugherty AL; Rangell LK; Eckert R; Zavala-Solorio J; Peale F; Mrsny RJ Eur J Pharm Biopharm; 2011 Jun; 78(2):289-97. PubMed ID: 21426936 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model. Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320 [TBL] [Abstract][Full Text] [Related]
20. An injectable, self-assembled multicellular microsphere with the incorporation of fibroblast-derived extracellular matrix for therapeutic angiogenesis. Du P; Da Costa ADS; Savitri C; Ha SS; Wang PY; Park K Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110961. PubMed ID: 32487382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]